{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:02:03Z","timestamp":1789560123772,"version":"build-2803163510"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:p>\n                    There are limited data on the causative agents and characteristics of drug-induced liver injury in pregnant individuals. Data from patients with drug-induced liver injury enrolled in the ongoing multicenter Drug-Induced Liver Injury Network between 2004 and 2022 and occurring during pregnancy or 6 months postpartum were reviewed and compared with cases of drug-induced liver injury in nonpregnant women of childbearing age. Among 325 individuals of childbearing age in the Drug-Induced Liver Injury Network, 16 cases of drug-induced liver injury (5%) occurred during pregnancy or postpartum. Compared with drug-induced liver injury in nonpregnant women, pregnancy-related drug-induced liver injury was more severe (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;.05). One elective termination and three miscarriages were documented; there were no maternal deaths. We recommend that isoniazid for latent tuberculosis be deferred to the postpartum period whenever feasible and that \u03b2-blockers or calcium channel blockers rather than methyldopa be used for hypertension management during pregnancy.\n                  <\/jats:p>","DOI":"10.1097\/aog.0000000000005585","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T17:04:48Z","timestamp":1713287088000},"page":"819-823","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Drug-Induced Liver Injury in Pregnancy"],"prefix":"10.1097","volume":"143","author":[{"given":"Umair","family":"Masood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Venturini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Dellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert L.","family":"Bonkovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiman","family":"Barnhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Vuppalanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Odin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Kushner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4,16]]},"reference":[{"key":"R1-20260916","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/hep.26175","article-title":"LiverTox: a website on drug-induced liver injury","volume":"57","author":"Hoofnagle","year":"2013","journal-title":"Hepatology"},{"key":"R2-20260916","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1007\/s10620-017-4812-7","article-title":"Identification and characterization of fenofibrate-induced liver injury","volume":"62","author":"Ahmad","year":"2017","journal-title":"Dig Dis Sci"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1111\/liv.12540","article-title":"Reliability of causality assessment for drug, herbal and dietary supplement hepatotoxicity in the Drug-Induced Liver Injury Network (DILIN)","volume":"35","author":"Hayashi","year":"2015","journal-title":"Liver Int"},{"key":"R4-20260916","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/hep.23577","article-title":"Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method","volume":"51","author":"Rockey","year":"2010","journal-title":"Hepatology"},{"key":"R5-20260916","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jhep.2021.12.043","article-title":"Value of liver biopsy in the diagnosis of drug-induced liver injury","volume":"76","author":"Ahmad","year":"2022","journal-title":"J Hepatol"},{"key":"R6-20260916","first-page":"1","article-title":"Births: final data for 2021","volume":"72","author":"Osterman","year":"2023","journal-title":"Natl Vital Stat Rep"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0895-4356(89)90020-6","article-title":"Assessing methods for causality assessment of suspected adverse drug reactions","volume":"42","author":"Hutchinson","year":"1989","journal-title":"J Clin Epidemiol"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/hep.29345","article-title":"Pregnancy outcome in women undergoing liver biopsy during pregnancy: a nationwide population-based cohort study","volume":"68","author":"Ludvigsson","year":"2018","journal-title":"Hepatology"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa2201295","article-title":"Treatment for mild chronic hypertension during pregnancy","volume":"386","author":"Tita","year":"2022","journal-title":"N Engl J Med"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jhep.2023.03.006","article-title":"EASL clinical practice guidelines on the management of liver diseases in pregnancy","volume":"79","year":"2023","journal-title":"J Hepatol"},{"key":"R11-20260916","first-page":"200111","article-title":"Pathophysiologically based antihypertensive pharmacotherapeutics rationality, efficacy and safety in Sub Saharan African Nations\u2014a review","volume":"11","author":"Ajayi","year":"2021","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"R12-20260916","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/08820130802205886","article-title":"Autoimmune disease during pregnancy and the microchimerism legacy of pregnancy","volume":"37","author":"Adams Waldorf","year":"2008","journal-title":"Immunol Invest"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005585","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:02:08Z","timestamp":1789556528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005585"}},"subtitle":["The U.S. Drug-Induced Liver Injury Network Experience"],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005585","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,16]]},"assertion":[{"value":"2024-01-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}